Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jerald Radich

Showing results (11-20 of 100) with videos related to

Pageof 10
Sort By:
Cancer Cell|September 10, 2014
Structure, function, and resistance in chronic myeloid leukemiaJerald Radich
Haematologica|July 1, 2026
Introduction to the Review Series. Chronic myeloid leukemia in 2026Jerald Radich
The New England Journal of Medicine|May 10, 2013
Genetically informed therapy in leukemiaJerald Radich
Plos Medicine|February 15, 2008
Solving the mystery of myelodysplasiaJerald Radich
Blood|April 29, 2017
Understanding CML, 1 cell at a timeJerald Radich
Clinical Lymphoma, Myeloma & Leukemia|August 23, 2015
Prognosis and Molecular Monitoring in Chronic Myeloid LeukemiaDaniel Egan, Jerald Radich
The New England Journal of Medicine|June 3, 2026
Chronic Myeloid Leukemia in Low- and Middle-Income Countries. ReplyAlicia Annamalay, Jerald Radich
Best Practice & Research. Clinical Haematology|November 15, 2016
Making the diagnosis, the tools, and risk stratification: More than just BCR-ABLDaniel Egan, Jerald Radich
Journal of the National Comprehensive Cancer Network : JNCCN|May 16, 2019
Optimizing Patient Care in Chronic Phase Chronic Myelogenous Leukemia: A Multidisciplinary ApproachHema Sundar, Jerald Radich
Current Opinion in Hematology|January 31, 2016
Is cure for chronic myeloid leukemia possible in the tyrosine kinase inhibitors era?Aasthaa Bansal, Jerald Radich
Pageof 10

Showing results (11-20 of 100) with videos related to

Sort By:
Pageof 10
Cancer Cell|September 10, 2014
Structure, function, and resistance in chronic myeloid leukemiaJerald Radich
Haematologica|July 1, 2026
Introduction to the Review Series. Chronic myeloid leukemia in 2026Jerald Radich
The New England Journal of Medicine|May 10, 2013
Genetically informed therapy in leukemiaJerald Radich
Plos Medicine|February 15, 2008
Solving the mystery of myelodysplasiaJerald Radich
Blood|April 29, 2017
Understanding CML, 1 cell at a timeJerald Radich
Clinical Lymphoma, Myeloma & Leukemia|August 23, 2015
Prognosis and Molecular Monitoring in Chronic Myeloid LeukemiaDaniel Egan, Jerald Radich
The New England Journal of Medicine|June 3, 2026
Chronic Myeloid Leukemia in Low- and Middle-Income Countries. ReplyAlicia Annamalay, Jerald Radich
Best Practice & Research. Clinical Haematology|November 15, 2016
Making the diagnosis, the tools, and risk stratification: More than just BCR-ABLDaniel Egan, Jerald Radich
Journal of the National Comprehensive Cancer Network : JNCCN|May 16, 2019
Optimizing Patient Care in Chronic Phase Chronic Myelogenous Leukemia: A Multidisciplinary ApproachHema Sundar, Jerald Radich
Current Opinion in Hematology|January 31, 2016
Is cure for chronic myeloid leukemia possible in the tyrosine kinase inhibitors era?Aasthaa Bansal, Jerald Radich
Pageof 10